Vasopressin: A therapeutic target in congestive heart failure?
- 31 December 1999
- journal article
- review article
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 5 (4) , 347-356
- https://doi.org/10.1016/s1071-9164(99)91339-8
Abstract
No abstract availableThis publication has 39 references indexed in Scilit:
- Vasopressin and a Nonpeptide Antidiuretic Hormone Receptor Antagonist (OPC-31260)Blood Pressure, 1994
- Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors.Journal of Clinical Investigation, 1993
- Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidusNature, 1992
- Molecular cloning and expression of a rat Via arginine vasopressin receptorNature, 1992
- OPC-21268, an Orally Effective, Nonpeptide Vasopressin V1 Receptor AntagonistScience, 1991
- Role of vasopressin in cardiovascular regulation.Physiological Reviews, 1988
- Response of Patients with Mild and Moderate Hemophilia A and von Willebrand's Disease to Treatment with DesmopressinAnnals of Internal Medicine, 1985
- Increased plasma arginine vasopressin levels in patients with congestive heart failureJournal of the American College of Cardiology, 1983
- Antidiuretic hormone in congestive heart failureThe American Journal of Medicine, 1982
- Radioimmunoassay of Plasma Arginine Vasopressin in Hyponatremic Patients with Congestive Heart FailureNew England Journal of Medicine, 1981